ASSOCIATION OF AZACITIDINE AND LENALIDOMIDE (COMBINATION VS SEQUENTIAL TREATMENT) FOR HIGH-RISK MYELODYSPLASTIC SYNDROMES (IPSS RISK: HIGH OR INT-2): A PHASE II CLINICAL AND BIOLOGICAL STUDY
Association of Azacitidine and Lenalidomide (combination vs sequential treatment) for high-rick myelodysplastic syndromes (IPSSrisk: hig or int-2): a phase II clinical and biological study
RIGOLIN, Gian Matteo;
2015
Abstract
ASSOCIATION OF AZACITIDINE AND LENALIDOMIDE (COMBINATION VS SEQUENTIAL TREATMENT) FOR HIGH-RISK MYELODYSPLASTIC SYNDROMES (IPSS RISK: HIGH OR INT-2): A PHASE II CLINICAL AND BIOLOGICAL STUDYFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
